GlassScriptPhysician profile
Arun G Dass
NPI 1700867017
$5,476.48
in general payments reported to CMS, 2019-2025
13 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $261 · 2021: $520 · 2022: $326 · 2023: $3,476 · 2024: $373 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,893 · Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,892.52 |
| Food and Beverage | $1,058.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $1,858.15 | 2022-2024 | Ovomotion, X-Twist, Drawtight |
| Medacta USA, INC. | $1,734.44 | 2023 | Amistem, Gmk Sphere, Primary Shoulder |
| Horizon Therapeutics Plc | $926.08 | 2019-2022 | |
| Stryker Corporation | $297.28 | 2019-2024 | Insignia |
| Next Science LLC | $136.31 | 2023 | Blastx, Xperience, Surgx |
| Welch Allyn | $129.11 | 2021 | |
| Sanara Medtech INC. | $101.68 | 2025 | Celleraterx |
| Zimmer Biomet Holdings, INC. | $95.19 | 2024 | Genex |
| Fx Shoulder Solutions, INC | $72.44 | 2019 | |
| Depuy Synthes Sales INC. | $56.50 | 2019 | |
| Trimed, INC. | $30.72 | 2024 | |
| Avanos Medical | $25.35 | 2024 | On-Q* Pump and Accessories |
| Axogen | $13.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Dass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.